Cytocom, Inc. CBLI
Set alert
3.17 +3.17 —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 226.39M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.08
- Inst. own
- 4.77%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 16, 2021
- 50-d avg
- 3.62
- 200-d avg
- 3.62
- 1y target
- 0.00
Analyst view
Consensus: none
Price target (mean) 0.00
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jan 24, 2014 | Cantor Fitzgerald | Downgrade | Buy | Hold |
| Mar 21, 2013 | Cantor Fitzgerald | Initiated | — | Buy |
| Mar 20, 2013 | Cantor Fitzgerald | Initiated | — | Buy |
| Dec 6, 2012 | Oppenheimer | Initiated | — | Outperform |
| Dec 4, 2012 | Burrill & Company | Initiated | — | Market Outperform |